Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
|
- ¥184000 - ¥303900
- 化學(xué)名: Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
- 英語名: LORAZEPAM RELATED COMPOUND E (25 MG) (6-CHLORO-4-(O-CHLOROPHENYL)-2-QUINAZOLINE METHA-NOL)
- 別名:Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
- CAS番號: 773871-49-1
- 分子式: C15H10Cl2N2O
- 分子量: 305.16
- EINECS:
- MDL Number:MFCD06202988
2物価
選択條件:
ブランド
- 富士フイルム和光純薬株式會社(wako)
- Sigma-Aldrich Japan
パッケージ
- 25mg
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01USP1370360
- 製品説明Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
- 英語製品説明Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
- 包裝単位25mg
- 価格¥303900
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號1370360
- 製品説明 United States Pharmacopeia (USP) Reference Standard
- 英語製品説明Lorazepam Related Compound E United States Pharmacopeia (USP) Reference Standard
- 包裝単位25mg
- 価格¥184000
- 更新しました2024-03-01
- 購入
| 生産者 | 製品番號 | 製品説明 | 包裝単位 | 価格 | 更新時間 | 購入 |
|---|---|---|---|---|---|---|
| 富士フイルム和光純薬株式會社(wako) | W01USP1370360 | Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol) Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol) |
25mg | ¥303900 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | 1370360 | United States Pharmacopeia (USP) Reference Standard Lorazepam Related Compound E United States Pharmacopeia (USP) Reference Standard |
25mg | ¥184000 | 2024-03-01 | 購入 |
プロパティ
沸點 :384.4±42.0 °C(Predicted)
比重(密度) :1.432±0.06 g/cm3(Predicted)
溶解性 :Chloroform (Slightly), Ethyl Acetate (Slightly)
酸解離定數(shù)(Pka) :11.92±0.10(Predicted)
主な用途 :pharmaceutical (small molecule)
InChI :1S/C15H10Cl2N2O/c16-9-5-6-13-11(7-9)15(19-14(8-20)18-13)10-3-1-2-4-12(10)17/h1-7,20H,8H2
InChIKey :FKDMILITBFQKKT-UHFFFAOYSA-N
SMILES :OCc1nc(-c2ccccc2Cl)c3cc(Cl)ccc3n1
比重(密度) :1.432±0.06 g/cm3(Predicted)
溶解性 :Chloroform (Slightly), Ethyl Acetate (Slightly)
酸解離定數(shù)(Pka) :11.92±0.10(Predicted)
主な用途 :pharmaceutical (small molecule)
InChI :1S/C15H10Cl2N2O/c16-9-5-6-13-11(7-9)15(19-14(8-20)18-13)10-3-1-2-4-12(10)17/h1-7,20H,8H2
InChIKey :FKDMILITBFQKKT-UHFFFAOYSA-N
SMILES :OCc1nc(-c2ccccc2Cl)c3cc(Cl)ccc3n1
安全情報
| 絵表示(GHS): |
![]()
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注意喚起語: | Danger | ||||||||||||||||||||||||||||
| 危険有害性情報: |
|
||||||||||||||||||||||||||||
| 注意書き: |
|
説明
関連商品価格
- 3-(3-クロロフェニルエチル)ピリジンN-オキシド
¥41300-438900 - 1-[[2-(4-Chlorophenyl)ethyl]amino]-2-chloropropane hydrochloride
¥72500-448500 - 3-クロロベンジル シアニド
¥5300-45160
供給者とメーカー
BOC Sciences
Sinco Pharmachem (ShenZhen) R&D Co., Ltd.
Amadis Chemical Company Limited
Quality Control Solutions Ltd.
Tianjin shijia biomedical technology co., LTD
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD
Energy Chemical
Changzhou Xianglong Pharmaceutical Technology Co., LTD
Cato Research Chemicals Inc.
Guangzhou Austine Biotechnology Co., LTD




